VIM-AS1 and urinary bladder cancer: Via serving as a ceRNA for miR-655, VIM-AS1 competed with ZEB1 for miR-655 binding, therefore eliminating miR-655-mediated suppression of ZEB1, finally affecting EMT in both high- and low-metastatic bladder cancer cells and cancer cell metastasis.